LH Laboratory Corp of America
- 201.370
- -2.800-1.37%
- 201.060
- -0.310-0.15%
Laboratory Corp of America News
Express News | NYSE Order Imbalance 75250.0 Shares on Sell Side
Baird Adjusts Laboratory Corp of America Holdings' Price Target to $255 From $244
Laboratory Corp of America Holdings (LH) has an average rating of outperform and price targets ranging from $210 to $262, according to analysts polled by Capital IQ.
Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Quest Diagnostics, LabCorp Climb Following FDA Testing Oversight Rule
Laboratory Corporation of America on Pace for Largest Percent Increase Since November 2022 -- Data Talk
Laboratory Corporation of America Holdings (LH) is currently at $206.91, up $8.51 or 4.29% --On pace for largest percent increase since Nov. 10, 2022, when it rose 5.44% --Currently up two consecuti
Express News | Labcorp Shares Are Trading Higher After the Company Announced That the FDA Approved Its NABCyte Anti-AAVRh74var HB-FE Assay, a Companion Diagnostic, to Determine Patient Eligibility for Treatment With BEQVEZ
Express News | FDA Approves Labcorp's NAbCyte Anti-AAVRh74var HB-FE, Companion Diagnostic To Determine Patient Eligibility For Treatment With Beqvez (Fidanacogene Elaparvovec-dzkt), Pfizer's Recently FDA-Approved Hemophilia B Gene Therapy
Express News | Labcorp Receives FDA Approval for First Companion Diagnostic for Use With Pfizer's Newly Approved Gene Therapy to Treat Patients With Hemophilia B
Analyst Ratings For Laboratory Corp
In the latest quarter, 5 analysts provided ratings for Laboratory Corp (NYSE:LH), showcasing a mix of bullish and bearish perspectives.The table below offers a condensed view of their recent ratings,
Laboratory Corp. Is Maintained at Outperform by Baird
Laboratory Corp. Is Maintained at Outperform by Baird
Express News | Baird Maintains Outperform on Laboratory Corp, Lowers Price Target to $244
Laboratory Corp Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/26/2024 22% Baird $255 → $244 Maintains Outperform 03/25/2024 — Argus Research Upgrades Hold → Buy 02/
Express News | Labcorp : Barclays Cuts Target Price to $213 From $234
Express News | Labcorp : Truist Securities Cuts Target Price to $255 From $270
Earnings Call Summary | Laboratory Corp of America(LH.US) Q1 2024 Earnings Conference
The following is a summary of the Laboratory Corporation of America Holdings (LH) Q1 2024 Earnings Call Transcript:Financial Performance:Labcorp's Q1 revenue reached $3.2 billion, a 5% increase from Q
Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal
Thursday, Labcorp (NYSE:LH) reported first-quarter sales increased 4.6% to $3.18 billion, beating the consensus of $3.12 billion. Base Business grew 6.7%.The increase was due to organic revenue of 2.3
Leerink Partners Adjusts Laboratory Corp of America Price Target to $242 From $260, Keeps Outperform Rating
Laboratory Corp of America Holdings (LH) has an average rating of outperform and price targets ranging from $220 to $270, according to analysts polled by Capital IQ. Price: 197.56, Change: -10.38, Per
Express News | Laboratory Corp Shares Are Trading Lower. The Company Reported Q1 Financial Results
Research Alert: CFRA Raises Opinion On Laboratory Corp. Of America Holdings To Buy From Hold
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our $225 target using forward P/
Laboratory Corp of America Q1 Adjusted Earnings, Revenue Increase; 2024 Adjusted EPS Outlook Updated
Laboratory Corp of America (LH) reported Q1 adjusted earnings Thursday of $3.68 per share, up from $3.46 a year earlier. Analysts polled by Capital IQ expected $3.48. Revenue for the quarter ended Mar
Analysis
Price Target
No Data
